Skip to main content

Table 6 Patient-reported outcomes in patients with and without care coordination during the campaign period

From: Impact of care coordination on oral anticoagulant therapy among patients with atrial fibrillation in routine clinical practice in Japan: a prospective, observational study

  With care coordination Without care coordination
MMAS-8 N = 13 N = 22
 Total score, median (IQR) 1 (1, 1.5) 1 (0.75, 1)
 Adherence levela, n (%)
  Low 13 (100.0) 22 (100.0)
  Medium 0 (0.0) 0 (0.0)
  High 0 (0.0) 0 (0.0)
ACTS score N = 14 N = 22
 Burden
  Burden score, median (IQR) 57.5 (55, 60) 59 (57, 60)
  Global question about burdens (Item 13), median (IQR) 1 (1, 2) 1 (1, 1)
 Benefit
  Benefit score, median (IQR) 10.5 (9, 12) 12.5 (11, 15)
  Global question about benefits (Item 17), median (IQR) 3 (3, 3) 4 (3, 5)
  1. Use of the©MMAS is protected by US and International copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, MMAS Research (MORISKY) 16,636 159th Place SE, Renton WA 98058, dmorisky@gmail.com
  2. Abbreviations: MMAS-8 Morisky 8-Item Medication Adherence Scale, ACTS Anti-Clot Treatment Scale, IQR Interquartile range
  3. aAdherence level: low adherence, total score < 6; medium adherence, total score 6 to < 8; high adherence, total score = 8